Brave Asset Management’s Cardlytics CDLX Stock Holding History

Brave Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-800	Closed	-$1.14M	–	148
2020 Q4	$1.14M	Sell	800 -55	-6%	-$58.7K	0.43%	39
2020 Q3	$603K	Buy	855 +130	+18%	+$94.5K	0.29%	49
2020 Q2	$507K	Sell	725 -50	-6%	-$28.9K	0.27%	51
2020 Q1	$271K	Sell	775 -375	-33%	-$266K	0.17%	78
2019 Q4	$723K	Hold	1,150	–	–	0.38%	55
2019 Q3	$385K	Buy	+1,150	New	+$369K	0.22%	75

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Brave Asset Management's CDLX Position: Q1 2021 in Review

Brave Asset Management sold out of Cardlytics (CDLX) in Q1 2021, closing a stake of 800 shares — an estimated $1.14M sold.

Brave Asset Management first reported a position in CDLX in Q3 2019 and held it in 6 quarters. The position peaked at $1.14M in Q4 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

Brave Asset Management reported no remaining Cardlytics position as of Q1 2021 after selling out during the quarter.
Brave Asset Management sold 800 Cardlytics shares in Q1 2021, an estimated $1.14M.
Brave Asset Management first reported a position in Cardlytics in Q3 2019 and held it in 6 quarters.
Brave Asset Management's Cardlytics position peaked at $1.14M in Q4 2020.
204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Brave Asset Management's 13F filing for Q1 2021, filed 26 Apr 2021.